THE FEATURES OF THE PREDICTIVE DISSOLUTION TESTING (REVIEW)
Abstract
Dissolution test plays an important role at different levels of the development and manufacturing drugs as one of the major quality control tools and an integral part of In vitro tests in the study of drug release from the developed dosage forms. Article describes the basic parameters that should be considered in predictive dissolution tests, such as the selection criteria and the composition of biorelevant dissolution media, fluid dynamics, volume and transfer of the dissolution media.
About the Authors
R. I. Moustafine
Kazan State Medical University
Russian Federation
Russian Federation
A. V. Sitenkova (Bukhovets)
Kazan State Medical University
Russian Federation
Russian Federation
N. Fotaki
University of Bath
Russian Federation
Russian Federation
References
1. Тест «Растворение» в разработке и регистрации лекарственных средств. Научно-практическое руководство для фармацевтической отрасли / Под ред. И.Е. Шохина - М.: Перо, 2015. 320 с.
2. Q. Wang, N. Fotaki, Y. Mao. Biorelevant Dissolution: Methodology and Application in Drug Development // Dissolution Technologyes. 2009. V. 16(3). P. 6-12.
3. D.S. Evans, G. Pye, R. Bramley, A.G. Clark, T.J. Dyson, J.D. Hardcastle. Measurement of gastrointestinal pH profiles in normal ambulant human subjects // Gut. 1988. V.29. № 8. P. 1035-1041.
4. J. Faallingborg, L.A. Christensen, M. Ingeman-Nielsen, B.A. Jacobsen, K. Abildgaard, H.H. Rasmussen. pH-profile and regional transit times of the normal gut measured by a radiotelemetry device // Aliment Pharmacology & Therapeutics. 1989. V. 3(6). P. 605-613.
5. S. Klein. In vitro release testing of controlled release formulations - from pharmacopeia to patient-specific methods // Evonik 10th International Controlled Release Workshop. 2015.
6. N. Fotaki, M. Vertzoni. Biorelevant Dissolution Methods and Their Applications in In Vitro-In Vivo Correlations for Oral Formulations // The Open Drug Delivery Journal. 2010. 4. Р. 2-13.
7. M. Koziolek, G. Garbacz, M. Neumann, W. Weitschies. Simulating the Postprandial Stomach: Biorelevant Test Methods for the Estimation of Intragastric Drug Dissolution // Molecular Pharmaceutics. 2013. V. 10(6). P. 2211-2221.
8. M. Vertzoni, J. Dressman, J. Butler, J. Hempenstall, Ch. Reppas. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds // European Journal of Pharmaceutics and Biopharmaceutics. 2005. V. 60. Р. 413-417.
9. E. Galia, E. Nicolaides, D. Horter, R. Lobenberg, Ch. Reppas, J. Dressman. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs // Pharmaceutical Research. 1998. V. 15(5). P. 698-705.
10. E. Jantratid, N. Janssen, Ch. Reppas, J. Dressman. Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An Update // Pharmaceutical Research. 2008. V. 25(7). P. 1663-1676.
11. G. Garbacz, B. Kolodziej, M. Koziolek, W. Weitschies, S. Klein. An Automated System for Monitoring and Regulating the pH of Bicarbonate Buffers // AAPS PharmSciTech. 2013. V. 14(20). P. 517-522.
12. M. Vertzoni, A. Diakidou, M. Chatzilias, E. Soderlind, B. Abrahamsson, J. Dressman, Ch. Reppas. Biorelevant Media to Simulate Fluids in the Ascending Colon of Humans and Their Usefulness in Predicting Intracolonic Drug Solubility // Pharmaceutical Research. 2010. V. 27(10). P. 2187-2196.
13. United States Pharmacopeia and National Formulary (USP 33 - NF 28). United States Pharmacopeial Convention, Inc. - Rockville, MD. USA. 2009 98.
14. Государственная фармакопея РФ, XIII изд. Т. 2. - М., 2015.
15. S. Aoki, K. Uesugi, K. Tatsuishi, H. Ozava, M. Kayano. Evaluation of the correlation between in vivo and in vitro release of phenylpropanolamine HCl from controlled-release tablets // International Journal of Pharmaceutics. 1992. V. 85. P. 65-73.
16. S. Aoki, H. Ando, K. Tatsuishi, K. Uesugi, H. Ozava. Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release // International Journal of Pharmaceutics. 1993. V. 95. P. 67-75.
17. N. Fotaki, A. Aivaliotis, J. Butler, J. Dressman, M. Fischbach, J. Hempenstall, S. Klein, Ch. Reppas. A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations // European Journal of Pharmaceutics and Bioharmaceutics. 2009. V. 73(1). P. 115-120.
18. G. Garbacz, S. Klein, W. Weitschies. A biorelevant dissolution stress test device - background and experience // Expert Opinion Drug Delivery. 2010. V. 7(11). P. 1251-1261.
19. I. Gonzalez-Garcia, V. Mangas-Sanjuan, M. Merina-Sanjuan, M. Bermejo. In vitro - in vivo correlations: general concepts, methodologies and regulatory applications // Drug Development and Industrial Pharmacy. 2015. V. 41(12). P. 1935-1947.
20. G. Garbacz, S. Klein. Dissolution testing of oral modified-release dosage forms // Journal of Pharmacy and Pharmacology. 2012. V. 64(7). P. 944-968.
21. S. Klein, N. Buchanan, Ch. Buchanan. Miniaturized Transfer Models to Predict the Precipitation of Poorly Soluble Weak Bases upon Entry into the Small Intestine // AAPS PharmSciTech. 2012. V. 13(4). P. 1230-1235.
22. T. Taupitz, J. Dressman, S. Klein. In Vitro Tools for Evaluating Novel Dosage Forms of Poorly Soluble, Weakly Basic Drugs: Case Example Ketoconazole // Journal of Pharmaceutical Sciences. 2013. P. 3645-3652.
Review
For citations:
Moustafine R.I., Sitenkova (Bukhovets) A.V., Fotaki N. THE FEATURES OF THE PREDICTIVE DISSOLUTION TESTING (REVIEW). Drug development & registration. 2017;(1):156-162. (In Russ.)
Views:
823
Email this article 